Showing results (1-10 of 146) with videos related to
Sort By:
Pageof 15
Expert Opinion on Investigational Drugs|July 11, 2009
Drugs in development for the treatment of schizophreniaRobin EmsleyEarly Intervention in Psychiatry|March 1, 2011
New advances in pharmacotherapy for early psychosisRobin EmsleyTherapeutic Advances in Psychopharmacology|September 13, 2023
Antipsychotics and structural brain changes: could treatment adherence explain the discrepant findings?Robin EmsleyCNS Drugs|May 25, 2007
Long-acting formulations of atypical antipsychotics: time to reconsider when to introduce depot antipsychoticsPierre Chue, Robin EmsleyThe Psychiatric Clinics of North America|April 10, 2003
The new and evolving pharmacotherapy of schizophreniaRobin Emsley, Piet OosthuizenNeuropsychiatric Disease and Treatment|January 31, 2018
Efficacy and safety profile of paliperidone palmitate injections in the management of patients with schizophrenia: an evidence-based reviewRobin Emsley, Sanja KilianThe International Journal of Neuropsychopharmacology|March 27, 2004
Evidence-based pharmacotherapy of schizophreniaRobin Emsley, Piet OosthuizenSchizophrenia Research|October 8, 2013
Is the ongoing use of placebo in relapse-prevention clinical trials in schizophrenia justified?Robin Emsley, Wolfgang W FleischhackerMetabolic Brain Disease|December 6, 2013
Alcohol-induced psychotic disorder: a reviewGerhard P Jordaan, Robin EmsleySchizophrenia Research|November 11, 2006
Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlatesRobin Emsley, Jonathan Rabinowitz, Rossella Medori, et al.Pageof 15